مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

754
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

4

Information Journal Paper

Title

EFFECT OF PREEMPTIVE MIDAZOLAM ON POST-ELECTROCONVULSIVE-THERAPY (ECT) HEADACHE, MYALGIA, AND NAUSEA AND VOMITING

Pages

  26-31

Abstract

 Background: ELECTROCONVULSIVE THERAPY (ECT) is a controlled electrical stimulus that affects central nervous system and leads to convulsion. Such as every other medical procedure, ELECTROCONVULSIVE THERAPY has some side effects like HEADACHE, MYALGIA, and NAUSEA and VOMITING. Patient undergoing ELECTROCONVULSIVE THERAPY receives deferent anesthetic drugs and some drugs like MIDAZOLAM, Atropine etc. to reduce side effects.Methods: This study included 40 patients who were candidates for receiving ELECTROCONVULSIVE THERAPY. By using convenience sampling, patients were divided into 2 groups of 20 people. MIDAZOLAM were given to one group while the other received placebo. Two patients in MIDAZOLAM group were removed because of short period of convulsion (lower than 20 seconds). The collected data were analyzed using independent t and chi-square tests.Findings: 16 men (42.1%) and 22 women (57.9%) were studied. The incidence of HEADACHE (P<0.001), MYALGIA (P=0.014) and VOMITING (P=0.011) was significantly higher in witness group. The incidence of coughing and laryngospasm was not significantly different between the two groups (P>0.050).Conclusion: MIDAZOLAM can reduce convulsion time but in most cases, convulsions last more than 25 seconds, which is in therapeutic range. So, it cannot affect the therapeutic value of ELECTROCONVULSIVE THERAPY. Preemptive MIDAZOLAM reduces Post-electroconvulsive-therapy HEADACHE, MYALGIA, and NAUSEA.

Cites

References

Cite

APA: Copy

NAZEMROAYA, BEHZAD, MOHAMMADI, AMIR HOSSEIN, NAJAFIAN, JAMSHID, & MORADI FARSANI, DARIOUSH. (2017). EFFECT OF PREEMPTIVE MIDAZOLAM ON POST-ELECTROCONVULSIVE-THERAPY (ECT) HEADACHE, MYALGIA, AND NAUSEA AND VOMITING. JOURNAL OF ISFAHAN MEDICAL SCHOOL (I.U.M.S), 35(417), 26-31. SID. https://sid.ir/paper/50025/en

Vancouver: Copy

NAZEMROAYA BEHZAD, MOHAMMADI AMIR HOSSEIN, NAJAFIAN JAMSHID, MORADI FARSANI DARIOUSH. EFFECT OF PREEMPTIVE MIDAZOLAM ON POST-ELECTROCONVULSIVE-THERAPY (ECT) HEADACHE, MYALGIA, AND NAUSEA AND VOMITING. JOURNAL OF ISFAHAN MEDICAL SCHOOL (I.U.M.S)[Internet]. 2017;35(417):26-31. Available from: https://sid.ir/paper/50025/en

IEEE: Copy

BEHZAD NAZEMROAYA, AMIR HOSSEIN MOHAMMADI, JAMSHID NAJAFIAN, and DARIOUSH MORADI FARSANI, “EFFECT OF PREEMPTIVE MIDAZOLAM ON POST-ELECTROCONVULSIVE-THERAPY (ECT) HEADACHE, MYALGIA, AND NAUSEA AND VOMITING,” JOURNAL OF ISFAHAN MEDICAL SCHOOL (I.U.M.S), vol. 35, no. 417, pp. 26–31, 2017, [Online]. Available: https://sid.ir/paper/50025/en

Related Journal Papers

Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top